Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
2.000
-0.040 (-1.96%)
At close: Dec 5, 2025, 4:00 PM EST
2.080
+0.080 (4.00%)
After-hours: Dec 5, 2025, 6:55 PM EST
Tivic Health Systems Revenue
Tivic Health Systems had revenue of $146.00K in the quarter ending September 30, 2025, with 15.87% growth. This brings the company's revenue in the last twelve months to $482.00K, down -49.63% year-over-year. In the year 2024, Tivic Health Systems had annual revenue of $780.00K, down -33.67%.
Revenue (ttm)
$482.00K
Revenue Growth
-49.63%
P/S Ratio
3.37
Revenue / Employee
$68,857
Employees
7
Market Cap
3.53M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TIVC News
- 18 days ago - Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome - Accesswire
- 21 days ago - Tivic Reports Third Quarter 2025 Financial Results - Accesswire
- 23 days ago - Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS) - Accesswire
- 26 days ago - Tivic Expands Intellectual Property Portfolio - Business Wire
- 4 weeks ago - Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast - Business Wire
- 6 weeks ago - Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23 - Business Wire
- 2 months ago - Tivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference - Business Wire
- 3 months ago - Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing - Business Wire